Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

06 sept. 2016 02h00 HE | Source: Veloxis Pharmaceuticals A/S

Veloxis Increases Share Capital in Connection with Exercise of Warrants

Company Announcement no. 20/2016 To: NASDAQ OMX Copenhagen A/S ...
31 août 2016 11h59 HE | Source: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals A/S Completes Closure of its Hørsholm, Denmark Office

Investor Service Announcement no. 5/2016 To: NASDAQ Copenhagen A/S ...
25 août 2016 11h47 HE | Source: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals A/S Establishes New Warrant Programme

Company Announcement no. 19/2016 To: NASDAQ Copenhagen A/S ...
24 août 2016 12h17 HE | Source: Veloxis Pharmaceuticals A/S

CORRECTION: Veloxis Pharmaceuticals Announces Financial Results for the First Six Months of 2016 and Provides Corporate Update

Highlights FDA approves label enhancement for Envarsus XR® which establishes dosing and PK profile in African-Americans and rapid metabolizers of tacrolimus Favorable signal...
24 août 2016 12h15 HE | Source: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals Announces Financial Results for the First Six Months of 2016 and Provides Corporate Update

Highlights FDA approves label enhancement for Envarsus XR® which establishes dosing and PK profile in African-Americans and rapid metabolizers of tacrolimus Favorable signal...
26 juil. 2016 11h27 HE | Source: Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals A/S - Passing of Extraordinary General Meeting

Company Announcement no. 17/2016 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, July...
01 juil. 2016 11h00 HE | Source: Veloxis Pharmaceuticals A/S

Notice to Convene Extraordinary General Meeting

Company Announcement no. 16 /2016 To: NASDAQ OMX Copenhagen A/S ...
30 juin 2016 03h00 HE | Source: Veloxis Pharmaceuticals A/S

Veloxis announces the total number of shares and voting rights in the company as of 30 June 2016

Company Announcement no. 15/2016 To: NASDAQ OMX Copenhagen...
28 juin 2016 22h33 HE | Source: Veloxis Pharmaceuticals A/S

Veloxis Receives Envarsus XR® Package Insert Label Enhancements Based on Study of African-American Transplant Recipients

Company Announcement no. 14/2016 To: NASDAQ OMX Copenhagen A/S ...
13 juin 2016 02h00 HE | Source: Veloxis Pharmaceuticals A/S

Veloxis increases share capital in connection with exercise of warrants

Company Announcement no. 13/2016 To: NASDAQ OMX Copenhagen...

Page précédente

Page suivante